ARHGAP22 and nonpapillary renal cell carcinoma: Based on our RNA-seq analysis, we found 4 novel genes (SCG5, SPOCD1, RGS19, and ARHGAP22) which were significantly downregulated in JQ1-treated-cells and may be promising and independent predictors for overall survival in patients with ccRCC.